Magenta Therapeutics Inc (MGTA)

Magenta Therapeutics (MGTA) Stock Price & Analysis


MGTA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.32 - $2.24
Previous Close$0.68
Average Volume (3M)502.75K
Market Cap
Enterprise Value-$38.74M
Total Cash (Recent Filing)$79.99M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-0.5
Aug 10, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.38
Shares Outstanding60,648,883
10 Day Avg. Volume368,784
30 Day Avg. Volume502,751
Standard Deviation0.24
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.44
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Magenta Therapeutics Inc’s price range in the past 12 months?
Magenta Therapeutics Inc lowest stock price was $0.32 and its highest was $2.24 in the past 12 months.
    What is Magenta Therapeutics Inc’s market cap?
    Currently, no data Available
    When is Magenta Therapeutics Inc’s upcoming earnings report date?
    Magenta Therapeutics Inc’s upcoming earnings report date is Aug 10, 2023 which is in 69 days.
      How were Magenta Therapeutics Inc’s earnings last quarter?
      Magenta Therapeutics Inc released its earnings results on May 11, 2023. The company reported -$0.47 earnings per share for the quarter, the consensus estimate of -$0.47 by $0.
        Is Magenta Therapeutics Inc overvalued?
        According to Wall Street analysts Magenta Therapeutics Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Magenta Therapeutics Inc pay dividends?
          Magenta Therapeutics Inc does not currently pay dividends.
          What is Magenta Therapeutics Inc’s EPS estimate?
          Magenta Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Magenta Therapeutics Inc have?
          Magenta Therapeutics Inc has 60,648,884 shares outstanding.
            What happened to Magenta Therapeutics Inc’s price movement after its last earnings report?
            Magenta Therapeutics Inc reported an EPS of -$0.47 in its last earnings report, expectations of -$0.47. Following the earnings report the stock price went down -4.225%.
              Which hedge fund is a major shareholder of Magenta Therapeutics Inc?
              Among the largest hedge funds holding Magenta Therapeutics Inc’s share is Western Standard Llc. It holds Magenta Therapeutics Inc’s shares valued at 1M.


                Magenta Therapeutics Stock Smart Score

                The Magenta Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Magenta Therapeutics Inc

                Magenta Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of novel medicines for bone marrow transplants. It offers platform that focuses on critical areas of transplant medicine. The company was founded by David Scadden, Derrick Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner in June 2015 and is headquartered in Cambridge, MA.


                Top 5 ETFs holding MGTA

                Market Value
                Smart Score
                iShares Core S&P Total U.S. Stock Market ETF
                Up to five ETFs with an Outperform Smart Score that hold MGTA. The ETFs are listed according to market value of MGTA within the ETF


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                G1 Therapeutics
                Crinetics Pharmaceuticals
                Mersana Therapeutics

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis